Factor VIII, human
Revision as of 00:57, 29 June 2024 by Warner-admin (talk | contribs) (Text replacement - "please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [https://online.lexi.com/lco/action/login UpToDate Lexidrug], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information" to "please refer to your preferred pharmacopeias or the prescribing information")
General information
Class/mechanism: Factor VIII; replaces the missing clotting factor VIII that is required for hemostasis in patients with hemophilia A.
Please choose from the products below to find specific drug/manufacturer information:
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.
Diseases for which it is used
- Hemophilia A
Also known as
- Generic name: coagulation factor 8
- Brand names: Hemofil-M, Koate-DVI, Koate-HP, Monarc-M, Monoclate-P
References
- ↑ Hemofil-M manufacturer's website
- ↑ Factor VIII, human (Hemofil-M) package insert
- ↑ File:Factorviiihemofil.pdf
- ↑ Koate-DVI manufacturer's website
- ↑ Factor VIII, human (Koate-DVI) package insert
- ↑ File:Factorviiikoate.pdf
- ↑ Factor VIII, human (Monarc-M) package insert
- ↑ File:Factorviiimonarc.pdf
- ↑ Monoclate-P manufacturer's website
- ↑ Factor VIII, human (Monoclate-P) package insert
- ↑ File:Factorviiimonoclate.pdf